The Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Anthracycline-Treated Patients With Cancer

BACKGROUND: Sodium glucose cotransporter-2 inhibitors (SGLT2is) are hypothesized to reduce the risk of anthracycline-associated cardiotoxicity. OBJECTIVES: This study sought to determine the association between SGLT2is and cardiovascular disease (CVD) after anthracycline-containing chemotherapy. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Qadir, Husam, Carrasco, Rodrigo, Austin, Peter C., Chen, Yue, Zhou, Limei, Fang, Jiming, Su, Henry M.H., Lega, Iliana C., Kaul, Padma, Neilan, Tomas G., Thavendiranathan, Paaladinesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308059/
https://www.ncbi.nlm.nih.gov/pubmed/37397088
http://dx.doi.org/10.1016/j.jaccao.2023.03.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308059/
https://www.ncbi.nlm.nih.gov/pubmed/37397088
http://dx.doi.org/10.1016/j.jaccao.2023.03.011

Ejemplares similares